Compugen Ltd. Share Price Deutsche Boerse AG
Stocks
CW9
IL0010852080
Biotechnology & Medical Research
| Market Cap | 20Cr 18Cr 17Cr 15Cr 29Cr 1.95TCr 29Cr 201.75Cr 79Cr 995.53Cr 76Cr 74Cr 3.19TCr | P/E 2026 * |
-7.61x | P/E 2027 * | -7.72x |
|---|---|---|---|---|---|
| Enterprise Value | 20Cr 18Cr 17Cr 15Cr 29Cr 1.95TCr 29Cr 201.75Cr 79Cr 995.53Cr 76Cr 74Cr 3.19TCr | EV / Sales 2026 * |
21.8x | EV / Sales 2027 * | 26x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compugen Ltd.
| 1 day | -2.88% |
| Manager | Title | Age | Since |
|---|---|---|---|
Eran Ophir
CEO | Chief Executive Officer | - | 23/09/2025 |
David Silberman
DFI | Director of Finance/CFO | 42 | 15/08/2024 |
Pierre Ferre
COO | Chief Operating Officer | 49 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Anat Cohen-Dayag
CHM | Chairman | 59 | 23/09/2025 |
Gilead Halevy
BRD | Director/Board Member | 59 | 11/06/2018 |
Sanford Zweifach
BRD | Director/Board Member | 70 | 11/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.88% | -9.82% | - | - | 20Cr | |
| -2.59% | -5.70% | +39.83% | +82.45% | 7.06TCr | |
| +3.23% | -10.67% | +4.87% | +55.97% | 5.1TCr | |
| +1.56% | +1.17% | +5.15% | +33.38% | 4.81TCr | |
| +0.39% | +0.65% | +28.02% | +30.24% | 4.28TCr | |
| +0.87% | -8.17% | +298.53% | +645.03% | 4.07TCr | |
| +1.24% | -1.01% | +5.56% | +105.14% | 4.03TCr | |
| -2.13% | -1.64% | +7.51% | +50.31% | 3.06TCr | |
| -0.46% | -1.28% | +31.47% | +19.93% | 2.82TCr | |
| +5.32% | +0.06% | -7.20% | -11.30% | 2.44TCr | |
| Average | +0.46% | -2.66% | +45.97% | +112.35% | 4.18TCr | |
| Weighted average by Cap. | +0.56% | -2.94% | +47.30% | +116.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 92.39L 82.51L 76.76L 69.82L 1.32Cr 89Cr 1.32Cr 9.24Cr 3.62Cr 46Cr 3.47Cr 3.39Cr 146.29Cr | 77.5L 69.22L 64.39L 58.57L 1.11Cr 75Cr 1.11Cr 7.75Cr 3.04Cr 38Cr 2.91Cr 2.85Cr 122.71Cr |
| Net income | -2.65Cr -2.36Cr -2.2Cr -2Cr -3.78Cr -256.13Cr -3.79Cr -26Cr -10Cr -130.58Cr -9.94Cr -9.72Cr -419.05Cr | -2.7Cr -2.41Cr -2.24Cr -2.04Cr -3.85Cr -260.83Cr -3.86Cr -27Cr -11Cr -132.98Cr -10Cr -9.9Cr -426.74Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
